{"prompt": "Please write a procedure note for Dr. Dr. Doe. Patient is a 68 year old male presenting with mediastinal lymphadenopathy. We performed EBUS TBNA on stations 11L, 4R, and 11Rs. ROSE cytology showed non-necrotizing granulomas. Elastography was Type 2.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 68-year-old male who presents with mediastinal lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nD86.0 Sarcoidosis of lung\n\nPOSTOPERATIVE DIAGNOSIS\nD86.0 Sarcoidosis of lung\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the bilateral mainstems and distal airways from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 11L (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nStation 11Rs (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n11L TBNA\n4R TBNA\n11Rs TBNA\n\nIMPRESSION / PLAN\n68-year-old male who presents for bronchoscopy for mediastinal lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of granulomatous inflammation consistent with Sarcoidosis.\nPreliminary cytology for stations 11L, 4R, and 11Rs Preliminary cytology suggestive of granulomas; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Generate EBUS report. 82yo F, lung mass with adenopathy. Stations 4L, 2L, 11L. ROSE: clusters of large atypical cells. Elastography Type 3. No complications.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 82-year-old female who presents with lung mass with adenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Bronchus Intermedius and Right Lower Lobe from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 4L (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 2L (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 11L (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n4L TBNA\n2L TBNA\n11L TBNA\n\nIMPRESSION / PLAN\n82-year-old female who presents for bronchoscopy for lung mass with adenopathy.\nOverall ROSE Diagnosis: Positive for Malignancy.\nPreliminary cytology for stations 4L, 2L, and 11L Preliminary cytology positive for malignant cells; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Patient: 79 M\nIndication: lung mass with adenopathy\nProcedure: EBUS\nNodes: 7, 4R, 4L\nFindings: Type 3, clusters of large atypical cells\nDoctor: Dr. Doe", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 79-year-old male who presents with lung mass with adenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Left Lower Lobe and Right Lower Lobe from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 7 (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 4L (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n7 TBNA\n4R TBNA\n4L TBNA\n\nIMPRESSION / PLAN\n79-year-old male who presents for bronchoscopy for lung mass with adenopathy.\nOverall ROSE Diagnosis: Positive for Malignancy.\nPreliminary cytology for stations 7, 4R, and 4L Preliminary cytology positive for malignant cells; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Patient: 79 M\nIndication: mediastinal lymphadenopathy\nProcedure: EBUS\nNodes: 11L, 4R, 11Rs\nFindings: Type 2, non-necrotizing granulomas\nDoctor: Dr. Doe", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 79-year-old male who presents with mediastinal lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nD86.0 Sarcoidosis of lung\n\nPOSTOPERATIVE DIAGNOSIS\nD86.0 Sarcoidosis of lung\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the bilateral mainstems and distal airways from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 11L (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nStation 11Rs (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n11L TBNA\n4R TBNA\n11Rs TBNA\n\nIMPRESSION / PLAN\n79-year-old male who presents for bronchoscopy for mediastinal lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of granulomatous inflammation consistent with Sarcoidosis.\nPreliminary cytology for stations 11L, 4R, and 11Rs Preliminary cytology suggestive of granulomas; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Patient: 74 F\nIndication: lymphadenopathy\nProcedure: EBUS\nNodes: 7, 4R, 4L\nFindings: Type 2, anthracotic pigments\nDoctor: Dr. Miller", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 74-year-old female who presents with lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPOSTOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Left Lower Lobe and Right Lower Lobe from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 7 (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 4L (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n7 TBNA\n4R TBNA\n4L TBNA\n\nIMPRESSION / PLAN\n74-year-old female who presents for bronchoscopy for lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of benign-appearing lymphoid tissue.\nPreliminary cytology for stations 7, 4R, and 4L Preliminary cytology suggestive of anthracotic pigments; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Patient: 62 F\nIndication: lymphadenopathy\nProcedure: EBUS\nNodes: 2R, 4R, 10R\nFindings: Type 2, anthracotic pigments\nDoctor: Dr. Bowers", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 62-year-old female who presents with lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPOSTOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 2R (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 10R (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n2R TBNA\n4R TBNA\n10R TBNA\n\nIMPRESSION / PLAN\n62-year-old female who presents for bronchoscopy for lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of benign-appearing lymphoid tissue.\nPreliminary cytology for stations 2R, 4R, and 10R Preliminary cytology suggestive of anthracotic pigments; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "65 F ebus for lymphadenopathy. sampled 2R 4R 10R. found anthracotic pigments, elastog type 2. pt stable.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 65-year-old female who presents with lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPOSTOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 2R (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 10R (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n2R TBNA\n4R TBNA\n10R TBNA\n\nIMPRESSION / PLAN\n65-year-old female who presents for bronchoscopy for lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of benign-appearing lymphoid tissue.\nPreliminary cytology for stations 2R, 4R, and 10R Preliminary cytology suggestive of anthracotic pigments; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "62 M ebus for lymphadenopathy. sampled 11L 4R 11Rs. found anthracotic pigments, elastog type 2. pt stable.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 62-year-old male who presents with lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPOSTOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the bilateral mainstems and distal airways from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 11L (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 11Rs (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n11L TBNA\n4R TBNA\n11Rs TBNA\n\nIMPRESSION / PLAN\n62-year-old male who presents for bronchoscopy for lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of benign-appearing lymphoid tissue.\nPreliminary cytology for stations 11L, 4R, and 11Rs Preliminary cytology suggestive of anthracotic pigments; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Op Report required. Codes 31645, 31653, 76982, 76983. Dx C34.90. Patient 85/F. Samples: 10R, 11R, 7 showing clusters of large atypical cells.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 85-year-old female who presents with lung mass with adenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the bilateral mainstems and distal airways from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 10R (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 11R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 7 (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n10R TBNA\n11R TBNA\n7 TBNA\n\nIMPRESSION / PLAN\n85-year-old female who presents for bronchoscopy for lung mass with adenopathy.\nOverall ROSE Diagnosis: Positive for Malignancy.\nPreliminary cytology for stations 10R, 11R, and 7 Preliminary cytology positive for malignant cells; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Please write a procedure note for Dr. Dr. Chen. Patient is a 62 year old male presenting with lung mass with adenopathy. We performed EBUS TBNA on stations 11L, 4R, and 11Rs. ROSE cytology showed clusters of large atypical cells. Elastography was Type 3.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 62-year-old male who presents with lung mass with adenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 11L (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 11Rs (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n11L TBNA\n4R TBNA\n11Rs TBNA\n\nIMPRESSION / PLAN\n62-year-old male who presents for bronchoscopy for lung mass with adenopathy.\nOverall ROSE Diagnosis: Positive for Malignancy.\nPreliminary cytology for stations 11L, 4R, and 11Rs Preliminary cytology positive for malignant cells; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Please write a procedure note for Dr. Dr. Miller. Patient is a 85 year old female presenting with lung mass with adenopathy. We performed EBUS TBNA on stations 7, 4R, and 4L. ROSE cytology showed clusters of large atypical cells. Elastography was Type 3.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 85-year-old female who presents with lung mass with adenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 7 (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 4L (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n7 TBNA\n4R TBNA\n4L TBNA\n\nIMPRESSION / PLAN\n85-year-old female who presents for bronchoscopy for lung mass with adenopathy.\nOverall ROSE Diagnosis: Positive for Malignancy.\nPreliminary cytology for stations 7, 4R, and 4L Preliminary cytology positive for malignant cells; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Op Report required. Codes 31645, 31653, 76982, 76983. Dx R59.0. Patient 85/F. Samples: 4L, 2L, 11L showing anthracotic pigments.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 85-year-old female who presents with lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPOSTOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Left Lower Lobe and Right Lower Lobe from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 4L (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 2L (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 11L (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n4L TBNA\n2L TBNA\n11L TBNA\n\nIMPRESSION / PLAN\n85-year-old female who presents for bronchoscopy for lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of benign-appearing lymphoid tissue.\nPreliminary cytology for stations 4L, 2L, and 11L Preliminary cytology suggestive of anthracotic pigments; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Generate EBUS report. 88yo F, lymphadenopathy. Stations 4L, 2L, 11L. ROSE: anthracotic pigments. Elastography Type 2. No complications.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 88-year-old female who presents with lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPOSTOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 4L (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 2L (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 11L (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n4L TBNA\n2L TBNA\n11L TBNA\n\nIMPRESSION / PLAN\n88-year-old female who presents for bronchoscopy for lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of benign-appearing lymphoid tissue.\nPreliminary cytology for stations 4L, 2L, and 11L Preliminary cytology suggestive of anthracotic pigments; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Please write a procedure note for Dr. Dr. Chen. Patient is a 88 year old male presenting with lung mass with adenopathy. We performed EBUS TBNA on stations 10R, 11R, and 7. ROSE cytology showed clusters of large atypical cells. Elastography was Type 3.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 88-year-old male who presents with lung mass with adenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 10R (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 11R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 7 (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n10R TBNA\n11R TBNA\n7 TBNA\n\nIMPRESSION / PLAN\n88-year-old male who presents for bronchoscopy for lung mass with adenopathy.\nOverall ROSE Diagnosis: Positive for Malignancy.\nPreliminary cytology for stations 10R, 11R, and 7 Preliminary cytology positive for malignant cells; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Please write a procedure note for Dr. Dr. Chen. Patient is a 88 year old female presenting with mediastinal lymphadenopathy. We performed EBUS TBNA on stations 7, 4R, and 4L. ROSE cytology showed non-necrotizing granulomas. Elastography was Type 2.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 88-year-old female who presents with mediastinal lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nD86.0 Sarcoidosis of lung\n\nPOSTOPERATIVE DIAGNOSIS\nD86.0 Sarcoidosis of lung\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Bronchus Intermedius and Right Lower Lobe from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 7 (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nStation 4L (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n7 TBNA\n4R TBNA\n4L TBNA\n\nIMPRESSION / PLAN\n88-year-old female who presents for bronchoscopy for mediastinal lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of granulomatous inflammation consistent with Sarcoidosis.\nPreliminary cytology for stations 7, 4R, and 4L Preliminary cytology suggestive of granulomas; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Patient: 68 F\nIndication: lymphadenopathy\nProcedure: EBUS\nNodes: 2R, 4R, 10R\nFindings: Type 2, anthracotic pigments\nDoctor: Dr. Chen", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 68-year-old female who presents with lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPOSTOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Left Lower Lobe and Right Lower Lobe from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 2R (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 10R (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n2R TBNA\n4R TBNA\n10R TBNA\n\nIMPRESSION / PLAN\n68-year-old female who presents for bronchoscopy for lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of benign-appearing lymphoid tissue.\nPreliminary cytology for stations 2R, 4R, and 10R Preliminary cytology suggestive of anthracotic pigments; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "65 F ebus for lymphadenopathy. sampled 7 4R 4L. found anthracotic pigments, elastog type 2. pt stable.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 65-year-old female who presents with lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPOSTOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Bronchus Intermedius and Right Lower Lobe from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 7 (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 4L (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n7 TBNA\n4R TBNA\n4L TBNA\n\nIMPRESSION / PLAN\n65-year-old female who presents for bronchoscopy for lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of benign-appearing lymphoid tissue.\nPreliminary cytology for stations 7, 4R, and 4L Preliminary cytology suggestive of anthracotic pigments; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Op Report required. Codes 31645, 31653, 76982, 76983. Dx C34.90. Patient 79/F. Samples: 7, 4R, 4L showing clusters of large atypical cells.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 79-year-old female who presents with lung mass with adenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPOSTOPERATIVE DIAGNOSIS\nC34.90 Malignant neoplasm of unspecified part of bronchus or lung\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Left Lower Lobe and Right Lower Lobe from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 7 (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nStation 4L (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 3 elastographic pattern with predominantly stiff regions (blue mapping).\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of clusters of large atypical cells.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n7 TBNA\n4R TBNA\n4L TBNA\n\nIMPRESSION / PLAN\n79-year-old female who presents for bronchoscopy for lung mass with adenopathy.\nOverall ROSE Diagnosis: Positive for Malignancy.\nPreliminary cytology for stations 7, 4R, and 4L Preliminary cytology positive for malignant cells; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Patient: 82 M\nIndication: lymphadenopathy\nProcedure: EBUS\nNodes: 2R, 4R, 10R\nFindings: Type 2, anthracotic pigments\nDoctor: Dr. Smith", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 82-year-old male who presents with lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPOSTOPERATIVE DIAGNOSIS\nR59.0 Localized enlarged lymph nodes\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Left Lower Lobe and Right Lower Lobe from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 2R (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 4R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nStation 10R (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed soft and stiff regions.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of anthracotic pigments.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n2R TBNA\n4R TBNA\n10R TBNA\n\nIMPRESSION / PLAN\n82-year-old male who presents for bronchoscopy for lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of benign-appearing lymphoid tissue.\nPreliminary cytology for stations 2R, 4R, and 10R Preliminary cytology suggestive of anthracotic pigments; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
{"prompt": "Please write a procedure note for Dr. Dr. Vasquez. Patient is a 65 year old male presenting with mediastinal lymphadenopathy. We performed EBUS TBNA on stations 10R, 11R, and 7. ROSE cytology showed non-necrotizing granulomas. Elastography was Type 2.", "completion": "INTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nINDICATION FOR OPERATION\n[REDACTED] is a 65-year-old male who presents with mediastinal lymphadenopathy. The nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail. The patient indicated a wish to proceed with surgery and informed consent was signed.\n\nPREOPERATIVE DIAGNOSIS\nD86.0 Sarcoidosis of lung\n\nPOSTOPERATIVE DIAGNOSIS\nD86.0 Sarcoidosis of lung\n\nPROCEDURE\n31645 Therapeutic aspiration initial episode\n31653 EBUS sampling 3 or more nodes\n76982 Ultrasound Elastography, First Target Lesion\n76983 Ultrasound Elastography, Additional Targets (x2)\n\nANESTHESIA\nGeneral Anesthesia\n\nMONITORING\nPulse oximetry, heart rate, telemetry, and BP were continuously monitored by an independent trained observer that was present throughout the entire procedure.\n\nINSTRUMENTATION\nFlexible Therapeutic Bronchoscope; Linear EBUS.\n\nESTIMATED BLOOD LOSS\nNone\n\nCOMPLICATIONS\nNone\n\nPROCEDURE IN DETAIL\nAfter the successful induction of anesthesia, a timeout was performed (confirming the patient's name, procedure type, and procedure location).\n\nInitial Airway Inspection & Therapeutic Aspiration\nSuccessful therapeutic aspiration was performed to clean out the Left Lower Lobe and Right Lower Lobe from mucus.\n\nEBUS Staging\nEndobronchial ultrasound (EBUS) was performed. All lymph node stations were assessed. Only those 5 mm or greater in short axis were sampled. Lymph node sizing was performed by EBUS and sampling was performed using 25-gauge and 22-gauge needles.\n\nEndobronchial ultrasound (EBUS) elastography was performed to assess lymph node stiffness and tissue characteristics. Elastography provided a semi-quantitative classification (Type 1\u20133), which was used to guide biopsy site selection and sampling strategy.\n\nLymph Nodes Evaluated:\n\nStation 10R (Site 1):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nStation 11R (Site 2):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nStation 7 (Site 3):\nAppearance: The lymph node was $\\ge$ 10 mm on CT and Hypermetabolic via PET-CT scan.\nElastography: The target lymph node demonstrated a Type 2 elastographic pattern with mixed patterns suggestive of inflammation.\nSampling: Given this appearance, TBNA was directed at representative areas. The site was sampled with 4 endobronchial ultrasound-guided transbronchial biopsies.\nROSE: Preliminary ROSE Cytology was reported as adequate and suggestive of non-necrotizing granulomas.\n\nConclusion\nThe patient tolerated the procedure well. There were no immediate complications. At the conclusion of the operation, the patient was extubated in the operating room and transported to the recovery room in stable condition.\n\nSPECIMENS\n10R TBNA\n11R TBNA\n7 TBNA\n\nIMPRESSION / PLAN\n65-year-old male who presents for bronchoscopy for mediastinal lymphadenopathy.\nOverall ROSE Diagnosis: Suggestive of granulomatous inflammation consistent with Sarcoidosis.\nPreliminary cytology for stations 10R, 11R, and 7 Preliminary cytology suggestive of granulomas; final results pending.\nFollow-up final pathology.\nFollow-up in clinic.\n"}
